Sessions
Opening Plenary Debate: The Cost on a Cure – Do The Results Justify The Price
Opening Plenary Panel: Thriving or Surviving – An Analysis of the Advanced Therapies Landscape Within Europe & What the Future Holds
Opening Plenary Debate: The Cost on a Cure – Do The Results Justify The Price
06 Sep 2023
09:45
Auditorium
Panel Participants:
Moderated by: Anthony Davies, Founder & Chief Executive Officer, Dark Horse Consulting Group
- Katrien Reynders, Board Member, HollandBIO
- Lucy Ellerker-Jones, Founder, Opie Jones Foundation
- Alexander Natz, Secretary General, European Confederation of Pharmaceutical Entrepreneurs (EUCOPE)
- Joshi Venugopal, General Manager, Head of Europe for Gene Therapies and Rare Diseases, Novartis Gene Therapies